Literature DB >> 12432915

Recent developments in cyclooxygenase inhibition.

Lawrence J Marnett1.   

Abstract

Recent studies of the mechanism and selectivity of inhibition of cyclooxygenase enzymes are reviewed. The structural determinants of inhibition by the non-selective inhibitor, aspirin, and COX-2-selective diarylheterocycles are considered. Kinetic investigations indicate that the time-dependence of binding and inhibition of COX-1 and COX-2 by diarylheterocycles is more complex than originally postulated. The selectivity of inhibition is not determined by differences in the rates of association of the inhibitors with the two enzymes but rather by differences in the rates of dissociation. New strategies for the development of COX-2-selective inhibitors are highlighted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12432915     DOI: 10.1016/s0090-6980(02)00027-8

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  8 in total

Review 1.  Cannabinoids and cancer: pros and cons of an antitumour strategy.

Authors:  Maurizio Bifulco; Chiara Laezza; Simona Pisanti; Patrizia Gazzerro
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

2.  Nitroarachidonic acid prevents NADPH oxidase assembly and superoxide radical production in activated macrophages.

Authors:  Lucía González-Perilli; María Noel Álvarez; Carolina Prolo; Rafael Radi; Homero Rubbo; Andrés Trostchansky
Journal:  Free Radic Biol Med       Date:  2013-01-11       Impact factor: 7.376

3.  Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.

Authors:  Shu Xu; Daniel J Hermanson; Surajit Banerjee; Kebreab Ghebreselasie; Gina M Clayton; R Michael Garavito; Lawrence J Marnett
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

Review 4.  Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond.

Authors:  Shu Xu; Carol A Rouzer; Lawrence J Marnett
Journal:  IUBMB Life       Date:  2014-12-23       Impact factor: 3.885

5.  Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxy-anandamide.

Authors:  L De Petrocellis; R Deva; F Mainieri; M Schaefer; T Bisogno; R Ciccoli; A Ligresti; K Hill; S Nigam; G Appendino; V Di Marzo
Journal:  J Lipid Res       Date:  2008-11-17       Impact factor: 5.922

6.  Nitroarachidonic acid, a novel peroxidase inhibitor of prostaglandin endoperoxide H synthases 1 and 2.

Authors:  Andrés Trostchansky; Lucía Bonilla; Christopher P Thomas; Valerie B O'Donnell; Lawrence J Marnett; Rafael Radi; Homero Rubbo
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

7.  Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth.

Authors:  Raquel Grau; Manuel D Díaz-Muñoz; Cristina Cacheiro-Llaguno; Manuel Fresno; Miguel A Iñiguez
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

8.  The effective interplay of (non-) selective NSAIDs with neostigmine in animal models of analgesia and inflammation.

Authors:  Mennatallah A Gowayed; Amany Abdel-Bary; Rasha A El-Tahan
Journal:  BMC Pharmacol Toxicol       Date:  2021-05-01       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.